Publications
Specialty
Search
Journal of Clinical Pathways
04/06/2024
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management, CardioVascular
04/05/2024
Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired. The transaction was approved by both companies’ boards of directors.
Wound Management & Prevention
04/05/2024
First Report Managed Care
04/05/2024
A Kaiser Family Foundation (KFF) report reveals the significant discrimination and unfair treatment faced by LGBT adults in the US, impacting mental health and access to health care, particularly for younger, lower-income, and women within the community.
Pharmacy Learning Network
04/05/2024
Par Sterile Products is recalling 466 vials of treprostinil injection because the solution may contain silicone particulates. The recall, which appeared in the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report, was designated Class I. The classification is the FDA’s most significant and warns use of the affected solution could cause serious adverse health consequences or death.
EP Lab Digest
04/05/2024
SAN DIEGO -- Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced the publication of data in the Journal of Cardiovascular Electrophysiology (JACE) demonstrating vMap’s ability to reduce the time from mapping to treatment, procedure duration, and fluoroscopy when treating cardiac arrhythmia patients with ablation therapy.
EP Lab Digest
04/05/2024
CHICAGO -- Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active Esophageal COOLing (EVERCOOL AF) study. The study is part of a multi-center observational study evaluating the impact of proactive esophageal cooling on patient outcome, throughput, and experience in high volume centers.
EP Lab Digest
04/05/2024
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes
Extends Johnson & Johnson MedTech’s Position in Highest-Growth, Innovation-Oriented Segments of Cardiovascular Intervention
Accelerates Sales Growth and Accretive to Operating Margin for Both Johnson & Johnson and Johnson & Johnson MedTech
Conference Call at 8:30 a.m. ET To Discuss Details of the Transaction
Lymphoma, Leukemia & Myeloma Network, Oncology
04/05/2024
Joshua Richter, MD, discusses promising novel advances in the multiple myeloma treatment landscape, including the use of T-cell redirection therapy and possible treatment approvals to come.
First Report Managed Care
04/05/2024
An expert panel proposed a pragmatic approach to diagnose and manage Demodex blepharitis in a recent study published in Eye.
First Report Managed Care
Identifying Large-Vessel Vasculitis in Polymyalgia Rheumatica: Key Clinical and Laboratory Red Flags
04/05/2024
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab test abnormalities, and insufficient response to 20 mg/day of prednisone, according to an editorial published in Clinical and Experimental Rheumatology.
First Report Managed Care, Population Health
04/05/2024
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
Psych Congress Network
04/05/2024
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Advances in Inflammatory Bowel Disease Network
04/05/2024
Investigators sought to determine the effects of hormone replacement therapy on disease activity among postmenopausal women with IBD.
Lymphoma, Leukemia & Myeloma Network, Oncology
04/05/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies, Joshua Richter, MD, explores the role of minimal residual disease in multiple myeloma treatment strategies, addressing whether it should be used to make clinical decisions for patients.
First Report Managed Care, Population Health
04/05/2024
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30 years ago, enables qualifying clinics and hospitals to purchase prescription drugs at discounted prices.
Advances in Inflammatory Bowel Disease Network
04/05/2024
Dr Jessica Allegretti reviewed the safety of IBD medications for pregnancy and breastfeeding at the Advances in Inflammatory Bowel Disease regional meeting in Boston on April 5.
EMSWorld
04/05/2024
After a 1,600-pound bison unexpectedly attacked 67-year-old Jim Lutter, Avel eCare was able to get him advanced treatment as quickly as possible. Discover how Avel eCare brings remote healthcare expertise to the community.
First Report Managed Care
04/05/2024
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
